Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

134 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Digoxin for the treatment of heart failure.
Hallberg P, Michaëlsson K, Melhus H. Hallberg P, et al. N Engl J Med. 2003 Feb 13;348(7):661-3; author reply 661-3. N Engl J Med. 2003. PMID: 12587575 No abstract available.
B2 bradykinin receptor (B2BKR) polymorphism and change in left ventricular mass in response to antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial.
Hallberg P, Lind L, Michaëlsson K, Karlsson J, Kurland L, Kahan T, Malmqvist K, Ohman KP, Nyström F, Melhus H. Hallberg P, et al. J Hypertens. 2003 Mar;21(3):621-4. doi: 10.1097/00004872-200303000-00029. J Hypertens. 2003. PMID: 12640257 Clinical Trial.
Transforming growth factor beta1 genotype and change in left ventricular mass during antihypertensive treatment--results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA).
Hallberg P, Lind L, Billberger K, Michaelsson K, Karlsson J, Kurland L, Kahan T, Malmqvist K, Ohman KP, Nyström F, Liljedahl U, Syvänen AC, Melhus H. Hallberg P, et al. Clin Cardiol. 2004 Mar;27(3):169-73. doi: 10.1002/clc.4960270315. Clin Cardiol. 2004. PMID: 15049387 Free PMC article. Clinical Trial.
Gender-specific association between preproendothelin-1 genotype and reduction of systolic blood pressure during antihypertensive treatment--results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA).
Hallberg P, Karlsson J, Lind L, Michaëlsson K, Kurland L, Kahan T, Malmqvist K, Ohman KP, Nyström F, Liljedahl U, Syvänen AC, Melhus H. Hallberg P, et al. Clin Cardiol. 2004 May;27(5):287-90. doi: 10.1002/clc.4960270510. Clin Cardiol. 2004. PMID: 15188945 Free PMC article. Clinical Trial.
134 results